Search by Journal
- HOME
- > Search by Journal
- > Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface
Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface
Volume , Issue suppl / 2017
![](/en/img/e.gif)
![](/en/img/j.gif)
- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
The Japanese Medical Society for Lung Surfactant and Biological Interface The 53rd Academic Society Introduction How to listen to this society 中田光1,2 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 2-6, 2017. |
---|
![]() |
Pulmonary surfactant lipid - basics and clinical practice 清水孝雄 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 8-17, 2017. |
---|
![]() |
Lipid balance abnormal significance in the onset of pulmonary fibrosis, the emphysema 松井弘樹1, 須永浩章1,2, 上野学2, 前野敏孝2, 磯達也2, 松坂賢3, 島野仁3, 倉林正彦2, 横山知行1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 20-29, 2017. |
---|
![]() |
Relation with a role and the lung disease in the pulmonary homeostasis of alveolus type II epithelial cells 諏訪部章1, 小笠原理恵1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 32-38, 2017. |
---|
![]() |
Disease by production, transportation of the pulmonary surfactant and the abnormality 長内和弘 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 40-45, 2017. |
---|
![]() |
Connection with resolution of the surfactant by the alveolus macrophage and abnormal - innovative drug development 赤川清子 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 48-55, 2017. |
---|
![]() |
Battle front of RDS treatment 長和俊1, 古瀬優太1, 夘月ゆたか1, 池田雅彦1, 恩田哲雄1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 58-63, 2017. |
---|
![]() |
Battle front of the condition of a patient and the treatment of the ARDS 内田寛治1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 66-72, 2017. |
---|
![]() |
GM-CSF inhalation therapy of the autoimmune alveolar proteinosis 田澤立之1, 鈴木雅2, 大河内眞也3, 朝川勝也1, 巽浩一郎4, 泉信有5, 石井晴之6, 山口悦郎7, 半田知宏8, 井上義一9, 富井啓介10, 江田良輔11, 森本浩之輔12, 三上礼子5, 田中崇裕1, 上田隆宏1, 北村信隆1, 中田光1,2 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 74-79, 2017. |
---|
![]() |
Pulmonary macrophage transplant treatment for the hereditary alveolar proteinosis 鈴木拓児1,2,3, 島賢治郎2, Paritha Armugam2,3, 萩原弘一1, Bruce Trapnell2,3 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 82-88, 2017. |
---|
![]() |
Battle front of cryptogenic fibrosing alveolitis treatment: Mainly on idiopathic pulmonary fibrosis 井上義一 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 90-97, 2017. |
---|
![]() |
Treatment strategy of the pulmonary alveolar microlithiasis 齋藤充史 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 100-106, 2017. |
---|
![]() |
A problem and the prospects in the diagnosis of the childhood onset nemaline myopathy hereditary interstitial lung disease 早坂格, 恩田哲雄, 池田雅彦, 秋元琢真, 古瀬優太, 長和俊 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 108-111, 2017. |
---|
![]() |
From hereditary interstitial lung disease (familial interstitial lung disease) and the diagnosis algorithm development to treatment 瀬戸口靖弘 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 114-119, 2017. |
---|
![]() |
Practice strategy in the secondary alveolar proteinosis 石井晴之1, 石田学2, 小田未来1, 本多紘二郎1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 122-129, 2017. |
---|
![]() |
AntiGM-CSF autoantibody sequence analysis of the autoimmune alveolar proteinosis using the next-generation sequencer 竹内志穂1, 橋本淳史1, 田澤立之1, 田中崇裕2, 北村信隆2, 奥田修二郎3, 中田光1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 132-132, 2017. |
---|
![]() |
The Role of Pulmonary Surfactant Lipids in the innate immunity of the Lung : NOVEL LIPID ANTIVIRALS Mari Numata-Nakamura1, Yury A. Bochkov4, Jennifer L. Tipper2, Yoji Nagashima3, Kevin S. Harrod2, Dennis R. Voelker1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 147-147, 2017. |
---|
![]() |
Study on mechanism of the drug-related interstitial pneumonia 萩原弘一1, 太田洋充2, 椎原淳2 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 160-164, 2017. |
---|
![]() |
Utilization to disease registry and innovative drug development in the pulmonary orphan disease 上田隆宏 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 166-171, 2017. |
---|
![]() |
We create genome innovative drug development industry from medical big data 若井俊文1, 亀山仁史1, 島田能史1, 永橋昌幸1, 市川寛1, 奥田修二郎2, 高部和明3 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 174-180, 2017. |
---|
![]() |
A-1. Change of the pulmonary surfactant synthetic pathway in the amiodarone pulmonary disorder rat experimental model 中瀬啓介1), 長内和弘1), 北楯祥子2), 佐久間貴士1), 西木一哲1), 野尻正史1), 加藤諒1), 高原豊1), 齋藤雅俊1), 小島好司1), 藤本由貴1), 及川卓1), 中川研1), 水野史朗1), 栂博久1) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 184-184, 2017. |
---|
![]() |
A-2. The mucous membrane Adjuvant SF-10 mixture oral administration influenza vaccine derived from human pulmonary surfactant induces general immunity and local immunity strongly 木本貴士, 堺聡子, 大野仁詩, 西山大喜, 高橋悦久, 木戸博 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 186-186, 2017. |
---|
![]() |
A-3. Pulmonary tissue constancy maintenance effect of the humoral factor derived from a marrow mesenchyma system stem cell 大河内眞也1, 小野学2,4, 沼倉忠久2,5, 兼平雅彦3, 岡田克典3, 黒澤一1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 188-188, 2017. |
---|
![]() |
A-4. Basic study of the periphery lungs epithelium stem cell 田中悠祐1,2, 角俊行1,2, 山口美樹1, 平井幸恵1, 渡辺敦3, 高橋弘毅2, 佐久間裕司1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 190-190, 2017. |
---|
![]() |
A-5. The endoplasmic reticulum stress inhibits efferocytosis through PERK course 伊藤博之, 山下嘉郎, 泉田真生, 高木理博, 田中健之, 森本浩之輔 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 192-192, 2017. |
---|
![]() |
A-6. Stimulation choice-like inflammatory reply adjustment function by aquaporin aquaporin 小森駿, 堀江一郎, 礒濱洋一郎 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 194-194, 2017. |
---|
![]() |
A-7. For the mass production of the type II alveolar cells using human iPS cells 山本佑樹1)2), 後藤慎平1)2), 興梠陽平1)2), 小西聡史1)2)3), 池尾聡1)2), 曽根尚之1)2), 玉井浩二1)2), 平井豊博1) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 196-196, 2017. |
---|
![]() |
A-8. Modeling of the Hermansky-Pudlak syndrome type 2 by the alveolus organoid derived from human iPS cells 興梠陽平1)2), 後藤慎平1)2), 山本佑樹1)2), 池尾聡1)2), 曽根尚之1)2), 小西聡史1)2)3), 玉井浩二1)2), 平井豊博1) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 198-198, 2017. |
---|
![]() |
B-1. Girls with 8 years old case of the autoimmune alveolar proteinosis maintaining a breathing state by total lung washing and the GM-CSF inhalation therapy of 20 several times after a diagnosis in three years 武藤雄一郎1), 右田昌宏1), 彌永和宏2), 大塚賀子3), 佐土原友弘3), 溝部孝則4) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 200-200, 2017. |
---|
![]() |
B-2. Serotonin and blood vessel permeability sthenia (Serotonin beyond the brain) - Sepsis, analysis (interim analysis) in the ARDS 田中健之1, 高木理博1, 関野元裕2, 森正彦3, 山下嘉郎1, 柿内聡志1, 田崎修4, 森本浩之輔1, 有吉紅也1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 202-202, 2017. |
---|
![]() |
B-3. Examination of the pulmonary fibrosis inhibitory effect of the basic FGF 王新涛1), 谷野功典1), 二階堂雄文1), 菊地正美1), 美佐健一1), 佐藤佑樹1), 東川隆一1), 谷野美智枝2), 棟方充1) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 206-206, 2017. |
---|
![]() |
B-4. Significance of the antiGM-CSF/HLA class II complex antibody in the autoimmune alveolar proteinosis 木田博1), 濱野芳匡1), 熊ノ郷淳1), 井上義一2), 新井徹2), 広瀬雅樹2), 松室昭子2), 末永忠広3), 荒瀬尚3) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 208-208, 2017. |
---|
![]() |
B-5. Clinical significance of the 50 percent inhibitory concentration of the GM-CSF-dependent cells proliferative capacity of the autoantibody out of the autoimmune alveolar proteinosis patient serum 小坂顕司, 山口悦郎, 米澤利幸, 柴田寛史, 加藤俊夫, 田中博之, 横江徳仁, 伊藤理, 久保昭仁 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 210-210, 2017. |
---|
![]() |
B-6. Examination about the transtime change and convalescence of blood biomarker in the idiopathic pulmonary fibrosis 山本裕子1, 祖開曉彦2, 半田知宏1, 谷澤公伸1,3, 宇野賀津子4, 池添浩平1, 中塚賀也1, 徳田深作1, 金谷久美子5, 久保武6, 小賀徹3, 長井苑子7, 陳和夫3, 三嶋理晃8, 平井豊博1 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 212-212, 2017. |
---|
![]() |
B-7. We estimate prevalence of the autoimmune alveolar proteinosis 吉澤和孝1), 北村信隆2), 坂上拓郎1), 田中崇裕2), 伊藤裕子3), 朝川勝明1), 高田俊範1), 小屋俊之1), 菊地利明1), 田澤立之3), 中田光3) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 214-214, 2017. |
---|
![]() |
B-8. The antiaquaporin 5 autoantibody which is detected in the serum of patients with Sjogren's syndrome 室井慎一, 本間宙生, 堀江一郎, 礒濱洋一郎 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 216-216, 2017. |
---|